Implication of human OCT4 transactivation domains for self-regulatory transcription

Biochemical and Biophysical Research Communications

Volumn 385, Issue 2, 2009, Pages 148-153

  Lim, Hye Young ^a,b   Do, Hyun Jin ^a   Lee, Won Young ^a,c   Kim, Dong Ku ^a   Seo, Han Geuk ^d   Chung, Hak Jae ^e   Park, Jin Ki ^e   Chang, Won Kyong ^e   Kim, Jin Hoi ^b   Kim, Jae Hwan ^a  

^a CHA Stem Cell Institute   (South Korea)

^b Konkuk University   (South Korea)

^c Konkuk University   (South Korea)

^d Gyeongsang National University School of Medicine   (South Korea)

^e National Institute of Animal Science   (South Korea)

Author keywords

Human OCT4; Human OCT4 promoter; NCCIT; Transactivation domain; Transcriptional activity

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR GAL4;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOREGULATION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL RENEWAL; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EMBRYONAL CARCINOMA STEM CELL; FEMALE; GENE DELETION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BINDING SITES; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 67349188104     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.029     Document Type: Article

References (31)

1. Schöler H.R., Ruppert S., Suzuki N., Chowdhury K., and Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 344 (1990) 435-439
2. Niwa H., Miyazaki J.I., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 (2000) 372-376
3. Pesce M., and Schöler H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19 (2001) 271-278
4. Gidekel S., Pizov G., Bergman Y., and Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4 (2003) 361-370
5. de Jong J., and Looijenga L.H. Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit. Rev. Oncog. 12 (2006) 171-203
6. Cheng C.J., Wu Y.C., Shu J.A., Ling T.Y., Kuo H.C., Wu J.Y., Chang E.E., Chang S.C., and Huang Y.H. Aberrant expression and distribution of the OCT-4 transcription factor in seminomas. J. Biomed. Sci. 14 (2007) 797-807
7. Ptashne M. How eukaryotic transcriptional activators works. Nature 335 (1988) 683-689
8. Mitchell P.J., and Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245 (1989) 371-378
9. Niwa H., Masui S., Chambers I., Smith A.G., and Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 22 (2002) 1526-1536
10. Triezenberg S.J. Structure and function of transcriptional activation domains. Curr. Opin. Genet. Dev. 5 (1995) 190-196
11. Attardi L.D., and Tjian R. Drosophila tissue-specific transcription factor NTF-1 contains a novel isoleucine-rich activation motif. Genes Dev. 7 (1993) 1341-1353
12. Estruch J.J., Crossland L., and Goff S.A. Plant activating sequences: positively charged peptides are functional as transcriptional activation domains. Nucleic Acids Res. 22 (1994) 3983-3989
13. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., and Staudt L.M. A POU-domain transcription factor in early stem cells, germ cells of the mammalian embryo. Nature 345 (1990) 686-692
14. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., and Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60 (1990) 461-472
15. Imagawa M., Miyamoto A., Shirakawa M., Hamada H., and Muramatsu M. Stringent integrity requirements for both trans-activation and DNA-binding in a trans-activator, Oct3. Nucleic Acids Res. 19 (1991) 4503-4508
16. Vigano M.A., and Staudt L.M. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. Nucleic Acids Res. 24 (1996) 2112-2118
17. Brehm A., Ohbo K., and Schöler H. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 17 (1997) 154-162
18. Do H.J., Lee W.Y., Lim H.Y., Oh J.H., Kim D.H., Kim J.H., Kim T., and Kim J.H. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells. J. Cell. Biochem. 106 (2009) 1079-1089
19. Schöler H.R., Balling R., Hatzopoulos A.K., Suzuki N., and Gruss P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J. 8 (1989) 2551-2557
20. Yang H.M., Do H.J., Oh J.H., Kim J.H., Choi S.Y., Cha K.Y., Chung H.M., and Kim J.H. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter. J. Cell. Biochem. 96 (2005) 821-830
21. Yang H.M., Do H.J., Kim D.K., Park J.K., Chang W.K., Chung H.M., Choi S.Y., and Kim J.H. Transcriptional regulation of human Oct4 by steroidogenic factor-1. J. Cell. Biochem. 101 (2007) 1198-1209
22. Chew J.L., Loh Y.H., Zhang W., Chen X., Tam W.L., Yeap L.S., Li P., Ang Y.S., Lim B., Robson P., and Ng H.H. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol. 25 (2005) 6031-6046
23. Schöler H.R., Ciesiolka T., and Gruss P. A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells. Cell 66 (1991) 291-304
24. Babaie Y., Herwig R., Greber B., Brink T.C., Wruck W., Groth D., Lehrach H., Burdon T., and Adjaye J. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25 (2007) 500-510
25. Tomioka M., Nishimoto M., Miyagi S., Katayanagi T., Fukui N., Niwa H., Muramatsu M., and Okuda A. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 30 (2002) 3202-3213
26. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., and Robson P. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280 (2005) 24731-24737
27. Clark A.T. The stem cell identity of testicular cancer. Stem Cell Rev. 3 (2007) 49-59
28. Ben-Shushan E., Thompson J.R., Gudas L.J., and Bergman Y. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell. Biol. 18 (1998) 1866-1878
29. Ezashi T., Ghosh D., and Roberts R.M. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4. Mol. Cell. Biol. 21 (2001) 7833-7891
30. Pan G., Li J., Zhou Y., Zheng H., and Pei D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J. 20 (2006) 1730-1732
31. Boer B., Kopp J., Mallann S., Desler M., Chakravarthy H., Wilder P.J., Bernadt C., and Rizzino A. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res. 35 (2007) 1773-1786